 |
|
Monash researchers lead the way in blood clotting discovery
May 26, 2009A Monash-led research team has discovered an entirely new mechanism that promotes blood clot formation - a major breakthrough that will impact on treatment and prevention of heart disease and stroke.
The discovery is today published in the prestigious Nature Medicine journal.
The discovery is the result of a decade-long research project led by Professor Shaun Jackson, Dr Warwick Nesbitt and Erik Westein from the Australian Centre for Blood Diseases (ACBD) at Monash University.
The study has discovered a new link between disturbed blood flow and blood clotting. ACBD research director Professor Shaun Jackson said that the association between disturbed blood flow and blood clotting was identified more than 150 years ago however it has proven extremely difficult to work out the mechanism by which blood flow activates the clotting mechanism.
"Changes in our arteries are a normal feature of the ageing process leading to disturbances in blood flow. Our work identifies the precise mechanism by which these blood flow changes activate the clotting process, increasing the risk of heart attack and stroke," Professor Jackson said.
Working in collaboration with scientists in the Department of Mechanical Engineering and the Division of Biological Engineering, Monash University and the School of Electronics and Computer Engineering at RMIT University in Melbourne, the ACBD researchers developed sophisticated new techniques that have helped define the link between disturbed blood flow and clot formation.
Lead author Dr Nesbitt explains that this new clotting mechanism is not sensitive to anti-clotting drugs, such as aspirin, clopidogrel or warfarin, defining an important new mechanism responsible for anti-clotting drug resistance.
"This discovery may partly explain the lack of effectiveness of commonly used anti-clotting therapies and may also lead to the development of new and innovative approaches to prevent heart disease and stroke." Dr Nesbitt said.
Blood clotting diseases are Australia's major healthcare problem affecting more than 50 per cent the adult population and kills one Australian nearly every ten minutes. The development of a clot in the circulation to the heart or brain (causing a heart attack or stroke, respectively) is an enormous clinical problem, responsible for more deaths in the community than any other disease.
Despite intense investigation over the last 40 years into the discovery and development of more effective anti-clotting drugs, the impact of these therapies on mortality rates has remained disappointingly low, with less than one in six patients taking anti-clotting therapies avoiding a fatal clotting event.
Mr Westein, co-lead author of the study, said the situation was likely to worsen in the future due to the rapidly growing incidence of obesity and diabetes. "People with diabetes are typically more resistant to the benefits of anti-clotting therapy, thus there is a pressing need for the identification and development of more effective approaches in the prevention of blood clotting," Mr Westein said.
Monash University
The study has discovered a new link between disturbed blood flow and blood clotting. ACBD research director Professor Shaun Jackson said that the association between disturbed blood flow and blood clotting was identified more than 150 years ago however it has proven extremely difficult to work out the mechanism by which blood flow activates the clotting mechanism.
"Changes in our arteries are a normal feature of the ageing process leading to disturbances in blood flow. Our work identifies the precise mechanism by which these blood flow changes activate the clotting process, increasing the risk of heart attack and stroke," Professor Jackson said.
Working in collaboration with scientists in the Department of Mechanical Engineering and the Division of Biological Engineering, Monash University and the School of Electronics and Computer Engineering at RMIT University in Melbourne, the ACBD researchers developed sophisticated new techniques that have helped define the link between disturbed blood flow and clot formation.
Lead author Dr Nesbitt explains that this new clotting mechanism is not sensitive to anti-clotting drugs, such as aspirin, clopidogrel or warfarin, defining an important new mechanism responsible for anti-clotting drug resistance.
"This discovery may partly explain the lack of effectiveness of commonly used anti-clotting therapies and may also lead to the development of new and innovative approaches to prevent heart disease and stroke." Dr Nesbitt said.
Blood clotting diseases are Australia's major healthcare problem affecting more than 50 per cent the adult population and kills one Australian nearly every ten minutes. The development of a clot in the circulation to the heart or brain (causing a heart attack or stroke, respectively) is an enormous clinical problem, responsible for more deaths in the community than any other disease.
Despite intense investigation over the last 40 years into the discovery and development of more effective anti-clotting drugs, the impact of these therapies on mortality rates has remained disappointingly low, with less than one in six patients taking anti-clotting therapies avoiding a fatal clotting event.
Mr Westein, co-lead author of the study, said the situation was likely to worsen in the future due to the rapidly growing incidence of obesity and diabetes. "People with diabetes are typically more resistant to the benefits of anti-clotting therapy, thus there is a pressing need for the identification and development of more effective approaches in the prevention of blood clotting," Mr Westein said.
Monash University
Blood Clotting Current Events and Blood Clotting News RSSAlternatively spliced tissue factor identified as promising new biomarker for aggressive cancers
A recently discovered form of the protein that triggers blood clotting may play a key role in the molecular mechanisms leading to the growth of certain metastatic cancers, according to new research reported by an international team of scientists.
'Superobesity,' chronic disease burden associated with risk of death following bariatric surgery
Veterans classified as superobese and those with a higher chronic disease burden appear more likely to die within a year of having bariatric surgery, according to a report in the October issue of Archives of Surgery, one of the JAMA/Archives journals.
Super sticky barnacle glue cures like blood clots
Barnacles are a big problem for boats. Adhering to the undersides of vessels, carpets of the crustaceans can increase fuel consumption by as much as 25%.
Liver cells grown from patients' skin cells
Scientists at The Medical College of Wisconsin in Milwaukee have successfully produced liver cells from patients' skin cells opening the possibility of treating a wide range of diseases that affect liver function.
New blood-thinning drug safer than rat poison
In an article reviewed by F1000 Medicine Faculty Members Robert Ruff, Brian Olshansky and Luis Ruilope, the blood-thinner dabigatran is shown to protect against stroke, blood clotting and major bleeding as effectively as warfarin, but with fewer side effects.
Scientists pinpoint protein link to fat storage
A protein found present in all cells in the body could help scientists better understand how we store fat.
New research confirms potential deadly nature of emerging new monkey malaria species in humans
Researchers in Malaysia have identified key laboratory and clinical features of an emerging new form of malaria infection.
Pregnancy complications are a stress test for future maternal health and pregnancies
Predicting whether pregnancy complications affect long-term maternal health as well as future pregnancies is at the heart of two studies conducted by researchers in the Department of Obstetrics, Gynecology and Reproductive Sciences at Yale School of Medicine.
New American College of Surgeons risk calculator determines colorectal surgery risk
New research published in the June issue of the Journal of the American College of Surgeons shows that a risk calculator developed by the American College of Surgeons (ACS) can help surgeons provide patients with more detailed and accurate preoperative information about the risk of death and complications following colorectal surgery.
Gene therapy technique thwarts cancer by cutting off tumor blood supply
University of Florida researchers have come up with a new gene therapy method to disrupt cancer growth by using a synthetic protein to induce blood clotting that cuts off a tumor's blood and nutrient supply.
More Blood Clotting Current Events and Blood Clotting News Articles
 |
Celox First Aid Temporary Traumatic Wound Treatment - 15g Pouch by SAMMedical CELOXTM is the newest generation of emergency hemostatic agents. Simpler to use and safer than older technologies, CELOX granules quickly control even severe arterial bleeding. Just pour it in, pack it, and apply pressure. No specific training is required. CELOX is not exothermic and won't burn the victim or caregiver. And CELOX works in hypothermic conditions and clots Heparinized blood. CELOX is safe to use for the entire body including head, neck and chest wounds. Most importantly, CELOX can be used instantly and without hesitation as a fast, safe and simple emergency treatment for serious bleeding. Average Time to Clot Whole Blood: 30.5 Seconds Average Time to Clot Heparinized Blood: 48 Seconds Controls Major Arterial Bleeding CELOXs unusual properties have been confirmed in wound... |
 |
First Aid Only Blood Clotting Spray M529 by Active Forever First Aid Only Blood Clotting Spray M529 |
 |
Adventure Medical QuikClot Sport Silver Clotting Sponge One Color, L by Adventure Medical No first aid kit is complete without the Adventure Medical Kits QuikClot Sport Silver Clotting Sponge. This chemically-inert material speeds the coagulation of moderate to severe bleeding until further medical attention arrives. QuikClot also contains ionic silver that stops bacteria from getting into the wound. Product FeaturesMaterial: Dimensions: [S] 3.5 x 3.5in (9 x 9cm); [L] 5 x 5in (13 x 13cm)Capacity / Volume: [S] .88oz (25g); [L] 1.75oz (50g)Weight: Recommended Use: Stopping bleedingManufacturer Warranty: |
|
5 Issues THE SURGICAL TECHNOLOGIST - Official Journal of the Association of Surgical Technologists, Inc. 2006 Volume 38 (Magazine. May, No. 5; June, No. 6; July, No. 7; September, No. 9; October, No. 10. Anterior Internal Fixation of Type II Odontoid Process Fractures;Ethics in the O.R. Setting;Left Ovarian Cystectomy.Blood Clotting Mechanism.) by Tom Borak (Editor) | |
 |
HemoClot Blood Clotting Gel, 1 oz. by Life Science Products HemoClot is an aid to stop bleeding in animals caused by minor cuts and wounds. It can be used for nail and beak trimming, tail docking, and ear cropping. Do not use in deep wounds or on burns |
 |
Your health and Victories in Medical Research. This baby llived because medical science has found a way to prevent hemorrhagic diseases in the newborn. Deficiency of vitamin K results in a subnormal amount of clotting substance in the blood. Thyloqinone, discovered at the Squbb Institute for Medical Research, has exceedingly high vitamin K activity and is a specific for the prevention and control of that hemorrhagic condition. This is a typical example of the way Squibb research is fighting disease and saving lives. Fighting diphtheria. Here you see diphtheria bacilli growing by the billions in special cultures at the Squibb Biological Laboratories. Diphtheria antitoxin is the chief reliance of physicians in fighting this disease. Squibb scientists have contributed to progress in concentrating the antitoxin, thus reducing the dosage volume to the advantage of the patient. ..... 1945 Squibb Ad, A5249A. life19451008 This Item is an original Magazine ad, taken from a vintage magazine of the year indicated. The ad is suitable for framing and displaying in your home or office. The scan of this item was taken through plastic film, however it is an accurate representation of the item. The nominal size is 10.5 inches by 14 inches. |
 |
First Aid Only Inc. Blood Clotting Spray 3 Oz. by First Aid Only Inc. First Aid Only Inc. Blood Clotting Spray 3 oz. : Blood clotting spray helps control superficial bleeding by forming an immediate porous, skin-like film over minor cuts and abrasions. Promotes healing and helps prevent infection. Contains no fluorocarbon |
 |
Understanding Hemophilia Part of the award winning public television series Healthy Body/Healthy Mind. Bleeding due to a cut or wound can be a little scary at times, especially if your child is a hemophiliac. Hemophiliacs lack specific blood proteins known as clotting factors that our bodies need to control bleeding following an injury. Fortunately, there is far more hope than ever before for these young patients. This episode features individuals with hemophilia who are successfully managing the disease in a manner that allows them to enjoy active and productive lives. This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply. |
 |
Botanic Choice Super EPA (Pack of 4) by Botanic Choice Omega 3 EFAs (Essential Fatty Acids) are essential for healthy arteries, blood pressure already in normal range, and triglycerides. The EFAs in cold water fish oil are believed to be the reasons why Greenland Eskimos (whose diet is mainly fish) are known for having such good heart and circulatory health. Two softgels of our high potency Super EPA Omega 3 fish oil give you 2000 mg. of fish oil and 1398 mg. of other beneficial fatty acids, 360 mg. of EPA and 240 mg. of DHA |
 |
Impaired Mobility: Physical Consequences (Immobility, Preventing Complications) (Volume One) Also With: Concept Media (Primary Contributor) Describes alterations in body functions occurring with impaired mobility. Common problems such as muscular atrophy, fluid and electrolyte disturbances, disorders in blood clotting mechanisms, disuse osteoporosis, retained respiratory secretions, and urinary stasis are discussed along with their long-term negative impact on patient health. |
| © 2009 BrightSurf.com |